Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hadley

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Ecology and Evolution|June 18, 2021
When are hypotheses useful in ecology and evolution?Matthew G Betts, Adam S Hadley, David W Frey, et al.
Journal of Medicinal Chemistry|May 5, 2000
Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3, 4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D(3) receptor antagonist with high oral bioavailability and CNS penetration in the ratG Stemp, T Ashmeade, C L Branch, et al.
Journal of Medicinal Chemistry|October 31, 2003
Design and synthesis of trans-3-(2-(4-((3-(3-(5-methyl-1,2,4-oxadiazolyl))- phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SB-414796): a potent and selective dopamine D3 receptor antagonistGregor J Macdonald, Clive L Branch, Michael S Hadley, et al.
Bioorganic & Medicinal Chemistry Letters|July 26, 2005
8-Piperazinyl-2,3-dihydropyrrolo[3,2-g]isoquinolines: potent, selective, orally bioavailable 5-HT1 receptor ligandsTom D Heightman, Laramie M Gaster, Sarah L Pardoe, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
3,4-Dihydro-2H-benzoxazinones are 5-HT(1A) receptor antagonists with potent 5-HT reuptake inhibitory activityPeter J Atkinson, Steven M Bromidge, Mark S Duxon, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2006
Studies towards the identification of a new generation of atypical antipsychotic agentsVincenzo Garzya, Ian T Forbes, Andrew D Gribble, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2000
Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-AC Reavill, S G Taylor, M D Wood, et al.
Science (New York, N.Y.)|December 7, 2019
Extinction filters mediate the global effects of habitat fragmentation on animalsMatthew G Betts, Christopher Wolf, Marion Pfeifer, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2026
High-quality surrounding landscapes mitigate avian extirpations from forest remnantsAnderson S Bueno, Chase D Mendenhall, Marina Anciães, et al.
Ecology and Evolution|June 27, 2014
BIOFRAG - a new database for analyzing BIOdiversity responses to forest FRAGmentationMarion Pfeifer, Veronique Lefebvre, Toby A Gardner, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Ecology and Evolution|June 18, 2021
When are hypotheses useful in ecology and evolution?Matthew G Betts, Adam S Hadley, David W Frey, et al.
Journal of Medicinal Chemistry|May 5, 2000
Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3, 4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D(3) receptor antagonist with high oral bioavailability and CNS penetration in the ratG Stemp, T Ashmeade, C L Branch, et al.
Journal of Medicinal Chemistry|October 31, 2003
Design and synthesis of trans-3-(2-(4-((3-(3-(5-methyl-1,2,4-oxadiazolyl))- phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SB-414796): a potent and selective dopamine D3 receptor antagonistGregor J Macdonald, Clive L Branch, Michael S Hadley, et al.
Bioorganic & Medicinal Chemistry Letters|July 26, 2005
8-Piperazinyl-2,3-dihydropyrrolo[3,2-g]isoquinolines: potent, selective, orally bioavailable 5-HT1 receptor ligandsTom D Heightman, Laramie M Gaster, Sarah L Pardoe, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
3,4-Dihydro-2H-benzoxazinones are 5-HT(1A) receptor antagonists with potent 5-HT reuptake inhibitory activityPeter J Atkinson, Steven M Bromidge, Mark S Duxon, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2006
Studies towards the identification of a new generation of atypical antipsychotic agentsVincenzo Garzya, Ian T Forbes, Andrew D Gribble, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2000
Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-AC Reavill, S G Taylor, M D Wood, et al.
Science (New York, N.Y.)|December 7, 2019
Extinction filters mediate the global effects of habitat fragmentation on animalsMatthew G Betts, Christopher Wolf, Marion Pfeifer, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2026
High-quality surrounding landscapes mitigate avian extirpations from forest remnantsAnderson S Bueno, Chase D Mendenhall, Marina Anciães, et al.
Ecology and Evolution|June 27, 2014
BIOFRAG - a new database for analyzing BIOdiversity responses to forest FRAGmentationMarion Pfeifer, Veronique Lefebvre, Toby A Gardner, et al.
Pageof 8